Tekla Capital Management
North America, Massachusetts, United States, Boston
Description
Tekla Capital Management is an investment adviser.
Investor Profile
Tekla Capital Management has backed more than 51 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 12% of its total and boasts 26 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series A rounds (top funding stages).
- Majority of deals are located in United States, Switzerland, Iceland.
- Strong thematic focus on Biotechnology, Health Care, Therapeutics.
Stage Focus
- Series B (31%)
- Series C (27%)
- Series A (16%)
- Post Ipo Equity (8%)
- Series E (6%)
- Series D (6%)
- Series Unknown (4%)
- Private Equity (2%)
Country Focus
- United States (73%)
- Switzerland (8%)
- Iceland (6%)
- France (4%)
- Canada (4%)
- The Netherlands (2%)
- United Kingdom (2%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Ireland (2%)
'/%3e%3cpath d='M200 752.362h200v300H200z' style='fill:%23fff;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3cpath d='M400 752.362h200v300H400z' style='fill:%23ff883e;fill-opacity:1;stroke:none' transform='translate(0 -752.362)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Biopharma
- Medical Device
- Life Science
- Oncology
- Developer Platform
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
